Classic Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Classic Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Pembrolizumab in Combination With Chemotherapy for the Treatment of Frail Hodgkin Lymphoma Patients Ineligible for Standard Treatment [Phase 2]
A Phase 2 trial is evaluating pembrolizumab in combination with chemotherapy for frail patients with classic Hodgkin lymphoma who are inelig…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL) [Phase 3]
A Phase III study is evaluating JS004 plus toripalimab versus investigator-selected chemotherapy in patients with PD-(L)1 monoclonal antibod…